Repligen Corporation Banner Image

Repligen Corporation

  • Ticker RGEN
    Exchange NASDAQ More
  • Industry Medical Instruments & Supplies More
  • Sector Healthcare More
Repligen Corporation Logo Image
  • 1001-5000 Employees
  • Based in Waltham, Massachusetts
Repligen Corporation (NASDAQ:RGEN) is a bioprocessing company focused on the development, manufacture and commercialization of highly innovative products used to improve the interconnected phases of the biological drug manufacturing process. Repligen's portfolio includes protein products (Protein A affinity ligands, cell culture growth factors), chromatography products (OPUS® pre-packedMore columns, chromatography resins, ELISA kits) and filtration products (XCell™ ATF Systems, TangenX™ Sius™ TFF cassettes). The company's bioprocessing products are sold to major life sciences companies, biopharmaceutical development companies and contract manufacturing organizations worldwide.
4.8 / 5.0 (68)

Repligen Corporation reports have an aggregate usefulness score of 4.8 based on 68 reviews.

Repligen Corporation

Most Recent Responsibility Report

Repligen Corporation
MOST RECENT 2020 Sustainability Report

Repligen Corporation does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Repligen Corporation Sustainability Report, Repligen Corporation Corporate Social Responsibility Report, Repligen Corporation CSR Report, Repligen Corporation Corporate Responsibility, Repligen Corporation CR Report, Repligen Corporation Citizenship Report, Repligen Corporation ESG Report, and Repligen Corporation Environmental Report online.
Repligen Corporation Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!